Clinical trial · Observational
A Study to Observe the Treatment Patterns and Outcomes of Patients in Japan With Kidney Cancer That is Unable to be Removed by Surgery or That Has Spread
Treatment Patterns and Outcomes in Unresectable or Metastatic Renal Cell Carcinoma (mRCC) Patients in Japan
NCT03161145CI-TRIAL-00029754completedClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
A medical review chart study in Japan to describe the treatment patterns and outcomes of patients with kidney cancer that is unable to be removed by surgery or that has spread. The clinical data is to be abstracted using electronic data capture (eDC) from patient medical records in Japan.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Renal Cell Carcinoma | Renal Cell Carcinoma | CURATED_BROADER | 0.80 |
Interventions
Interventions (0)
Data not yet available
No intervention recorded.
Design
Arms and outcomes
Arms (1)
- label
- Unresectable or metastatic renal cell carcinoma (mRCC)
- description
- Medical records will be reviewed for treatment patterns and outcomes
Primary outcomes (4)
- measure
- Treatment patterns
- timeFrame
- Approximately 5 years
- description
- measured by retrospective data collection of treatment regimen and duration (including rate of permanent and temporary discontinuation)
- measure
- Overall survival
- timeFrame
- Approximately 2 years
- description
- measured by data collection in years
- measure
- Reason for terminating or switching treatment
- timeFrame
- Approximately 5 years
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 20 Years
Show eligibility criteria text
For more information regarding Bristol-Myers Squibb Clinical Trial participation, please visit www.BMSStudyConnect.com Inclusion Criteria: * Adults 20 years and older at the time of initial diagnosis of mRCC * Alive or deceased as of the date of data collection * Diagnosis of mRCC between 01-Jan-2012 and 31-Aug-2015 Exclusion Criteria: * Previously and/or currently enrolled in RCC clinical trials * Patients have primary cancer other than renal cell cancer
References
Publications (0)
Data not yet available
No reference posted for this study.